Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA Early versus delayed use of Sofosbuvir plus Peginterferon/Ribavirin therapy in fibrosis patients with hepatitis C virus: A cost-effectiveness analysis 50th International Liver Congress (EASL). Vienna, Austria. 22- 26 apr 2015 POSTER
Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MAButi M, Dominguez R, Oyagüez I, Rueda M, Casado MA